Evidence map›Paper›PMID 41977338›Full record

ArticleInternational journal of molecular sciences2026

Clinical Value of Neutrophil Gelatinase-Associated Lipocalin as a Non-Invasive Biomarker for Intestinal Ulcer in Behçet's Syndrome: A Pilot Study.

Jing-Fen Ye, Yi-Xuan Zhang, Dan Hu, Jian-Fei Cai, Yu-Xin Liu, Li-Yang Zhang, Jun Zou, Jian-Long Guan

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing-Fen YeDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Yi-Xuan ZhangDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Dan HuDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Jian-Fei CaiDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Yu-Xin LiuDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Li-Yang ZhangDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Jun ZouDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
Jian-Long GuanDepartment of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.ORCID 0000-0002-6481-480X

Funding

This research was supported by the clinical study on the value of fecal neutrophil gelatinase-associated lipocalin in the early diagnosis of intestinal Behçe't disease 20234Y0110
6 · The paper itself

Abstract

Intestinal Behçet's syndrome (BS) is a severe phenotype associated with high morbidity and mortality. Early identification of intestinal involvement in BS remains clinically challenging due to the lack of reliable biomarkers. Neutrophil gelatinase-associated lipocalin (NGAL) is abundantly secreted during intestinal inflammation and has been recognized as a promising inflammatory biomarker. This study was designed to investigate the clinical value of NGAL for predicting intestinal involvement in BS patients. BS patients who underwent colonoscopy for suspected intestinal lesions were enrolled and classified into intestinal BS and non-intestinal BS groups. Immunohistochemistry was performed to compare colonic mucosal NGAL expression among intestinal BS, non-intestinal BS, inflammatory bowel disease (IBD) patients, and healthy controls. Serum and fecal NGAL levels were also measured in intestinal BS, non-intestinal BS, and healthy controls. Intestinal mucosal NGAL expression was significantly elevated in both intestinal BS and IBD patients, with no significant difference between the two groups. Serum and fecal NGAL levels were both higher in intestinal BS patients than in healthy controls. Notably, only fecal NGAL was significantly increased in intestinal BS compared to non-intestinal BS (

Indexed as

Behcet SyndromeIntestinal DiseasesLipocalin-2UlcerAdultBiomarkersCase-Control StudiesFecesFemaleHumansIntestinal MucosaMaleMiddle AgedPilot ProjectsBiomarkersLCN2 protein, humanLipocalin-2biomarkerintestinal Behçet’s syndromeneutrophil gelatinase-associated lipocalin2

Identifiers

PMID41977338
PMCPMC13073483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.